Cite Filings / DMRA / 0001193125-26-047007

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Damora Therapeutics, Inc. Filed 2026-02-11 Acc 0001193125-26-047007

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2026-02-11 SCHEDULE 13D/A Beneficial Ownership Report
2026-02-11 8-K Material agreement
2026-02-11 424B5 Prospectus
2026-02-10 424B5 Prospectus
2026-02-10 S-3ASR Registration Statement
2026-02-10 8-K Executive or director change · Bylaws or fiscal year change · Other events
2025-10-09 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…